Aurinia Pharmaceuticals Statistics
Total Valuation
AUPH has a market cap or net worth of $1.97 billion. The enterprise value is $1.66 billion.
Important Dates
The last earnings date was Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AUPH has 128.60 million shares outstanding. The number of shares has decreased by -5.95% in one year.
| Current Share Class | 128.60M |
| Shares Outstanding | 128.60M |
| Shares Change (YoY) | -5.95% |
| Shares Change (QoQ) | -0.38% |
| Owned by Insiders (%) | 0.96% |
| Owned by Institutions (%) | 62.80% |
| Float | 126.24M |
Valuation Ratios
The trailing PE ratio is 7.03 and the forward PE ratio is 15.30.
| PE Ratio | 7.03 |
| Forward PE | 15.30 |
| PS Ratio | 6.59 |
| Forward PS | 7.83 |
| PB Ratio | 3.52 |
| P/TBV Ratio | 3.48 |
| P/FCF Ratio | 11.79 |
| P/OCF Ratio | 11.77 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.77, with an EV/FCF ratio of 9.93.
| EV / Earnings | 5.55 |
| EV / Sales | 5.55 |
| EV / EBITDA | 10.77 |
| EV / EBIT | 12.32 |
| EV / FCF | 9.93 |
Financial Position
The company has a current ratio of 5.55, with a Debt / Equity ratio of 0.12.
| Current Ratio | 5.55 |
| Quick Ratio | 4.95 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.44 |
| Debt / FCF | 0.41 |
| Interest Coverage | 31.42 |
Financial Efficiency
Return on equity (ROE) is 64.98% and return on invested capital (ROIC) is 52.06%.
| Return on Equity (ROE) | 64.98% |
| Return on Assets (ROA) | 13.66% |
| Return on Invested Capital (ROIC) | 52.06% |
| Return on Capital Employed (ROCE) | 21.07% |
| Weighted Average Cost of Capital (WACC) | 11.95% |
| Revenue Per Employee | $2.33M |
| Profits Per Employee | $2.33M |
| Employee Count | 128 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.40 |
Taxes
| Income Tax | -164.48M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +94.65% in the last 52 weeks. The beta is 1.45, so AUPH's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | +94.65% |
| 50-Day Moving Average | 15.30 |
| 200-Day Moving Average | 14.12 |
| Relative Strength Index (RSI) | 45.51 |
| Average Volume (20 Days) | 1,249,714 |
Short Selling Information
The latest short interest is 8.89 million, so 6.91% of the outstanding shares have been sold short.
| Short Interest | 8.89M |
| Short Previous Month | 9.11M |
| Short % of Shares Out | 6.91% |
| Short % of Float | 7.04% |
| Short Ratio (days to cover) | 8.07 |
Income Statement
In the last 12 months, AUPH had revenue of $298.30 million and earned $298.21 million in profits. Earnings per share was $2.17.
| Revenue | 298.30M |
| Gross Profit | 233.47M |
| Operating Income | 134.30M |
| Pretax Income | 133.73M |
| Net Income | 298.21M |
| EBITDA | 153.71M |
| EBIT | 134.30M |
| Earnings Per Share (EPS) | $2.17 |
Full Income StatementBalance Sheet
The company has $378.52 million in cash and $68.64 million in debt, with a net cash position of $309.88 million or $2.41 per share.
| Cash & Cash Equivalents | 378.52M |
| Total Debt | 68.64M |
| Net Cash | 309.88M |
| Net Cash Per Share | $2.41 |
| Equity (Book Value) | 567.63M |
| Book Value Per Share | 4.34 |
| Working Capital | 393.69M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $166.92 million and capital expenditures -$274,000, giving a free cash flow of $166.64 million.
| Operating Cash Flow | 166.92M |
| Capital Expenditures | -274,000 |
| Depreciation & Amortization | 19.41M |
| Net Borrowing | -14.02M |
| Free Cash Flow | 166.64M |
| FCF Per Share | $1.30 |
Full Cash Flow StatementMargins
Gross margin is 78.27%, with operating and profit margins of 45.02% and 99.97%.
| Gross Margin | 78.27% |
| Operating Margin | 45.02% |
| Pretax Margin | 44.83% |
| Profit Margin | 99.97% |
| EBITDA Margin | 51.53% |
| EBIT Margin | 45.02% |
| FCF Margin | 55.87% |
Dividends & Yields
AUPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.95% |
| Shareholder Yield | 5.95% |
| Earnings Yield | 15.18% |
| FCF Yield | 8.48% |
Analyst Forecast
The average price target for AUPH is $17.25, which is 12.89% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.25 |
| Price Target Difference | 12.89% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 14.42% |
| EPS Growth Forecast (5Y) | 1.77% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on October 23, 2013. It was a reverse split with a ratio of 1:50.
| Last Split Date | Oct 23, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
AUPH has an Altman Z-Score of 6.57 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.57 |
| Piotroski F-Score | 4 |
